The outcome of a national MS-Covid-19 study: What the Turkish MS cohort reveals?
Sedat Şen, Rana Karabudak, Irene Schiavetti, Serkan Demir, Serkan Özakbaş, Melih Tütüncü, Belgin Petek Balcı, Ömer Faruk Turan, Cihat Uzunköprü, Mesrure Köseoğlu, Mehmet Fatih Yetkin, Tuncay Gündüz, H. Gumus, N. Kale Icen, Luca Carmisciano, Murat Terzi, Pınar Acar, İpek Güngör Doğan, Cavid Baba, A. Tuncer, Uğur Uygunoğlu, Maria Pia Sormani, Hüsnü Efendi, Aksel Sıva
Topics & Concepts
MedicineTurkishMultiple sclerosisCoronavirus disease 2019 (COVID-19)Cohort2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Cohort studyVirologyInternal medicinePsychiatryDiseaseOutbreakInfectious disease (medical specialty)PhilosophyLinguisticsSARS-CoV-2 and COVID-19 ResearchMultiple Sclerosis Research StudiesLong-Term Effects of COVID-19